Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Apyx Medical Corp has a consensus price target of $6.63 based on the ratings of 6 analysts. The high is $9 issued by Lake Street on June 15, 2023. The low is $4.5 issued by Piper Sandler on August 11, 2023. The 3 most-recent analyst ratings were released by Citizens, Stephens & Co., and Piper Sandler on November 12, 2025, November 10, 2023, and August 11, 2023, respectively. With an average price target of $5.83 between Citizens, Stephens & Co., and Piper Sandler, there's an implied 50.93% upside for Apyx Medical Corp from these most-recent analyst ratings.
1calculated from analyst ratings
| Get Alert | |||||
|---|---|---|---|---|---|
| Nov 12, 2025 | 106.99% | 8 | Previous Market Perform Current Market Outperform | Get Alert | |
| Oct 17, 2024 | — | — | Previous Initiates Current Neutral | Get Alert | |
| Sep 16, 2024 | — | — | Previous Current Market Perform | Get Alert | |
| Nov 10, 2023 | 29.37% | 58 | Previous Overweight Current Overweight | Get Alert | |
| Aug 11, 2023 | 16.43% | 44.5 | Previous Overweight Current Overweight | Get Alert | |
| Jul 14, 2023 | 106.99% | 8 | Previous Initiates Current Overweight | Get Alert | |
| Jun 15, 2023 | 132.86% | 69 | Previous Current Buy | Get Alert | |
| May 24, 2023 | — | — | Previous Current Market Perform | Get Alert | |
| May 12, 2023 | 55.24% | 56 | Previous Buy Current Buy | Get Alert |
The latest price target for Apyx Medical (NASDAQ:APYX) was reported by Citizens on November 12, 2025. The analyst firm set a price target for $8.00 expecting APYX to rise to within 12 months (a possible 106.99% upside). 1 analyst firms have reported ratings in the last year.
The latest analyst rating for Apyx Medical (NASDAQ:APYX) was provided by Citizens, and Apyx Medical upgraded their market outperform rating.
The last upgrade for Apyx Medical Corp happened on November 12, 2025 when Citizens raised their price target to $8. Citizens previously had a market perform for Apyx Medical Corp.
There is no last downgrade for Apyx Medical.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Apyx Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Apyx Medical was filed on November 12, 2025 so you should expect the next rating to be made available sometime around November 12, 2026.
While ratings are subjective and will change, the latest Apyx Medical (APYX) rating was a upgraded with a price target of $0.00 to $8.00. The current price Apyx Medical (APYX) is trading at is $3.87, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.